These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9652865)

  • 1. Monte Carlo-based dose-rate tables for the Amersham CDCS.J and 3M model 6500 137Cs tubes.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):959-70. PubMed ID: 9652865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monte Carlo calculations of dose rate distributions around the Amersham CDCS-M-type 137Cs source.
    Casal E; Ballester F; Lluch JL; Pérez-Calatayud J; Lliso F
    Med Phys; 2000 Jan; 27(1):132-40. PubMed ID: 10659748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sievert integral revisited: evaluation and extension to 125I, 169Yb, and 192Ir brachytherapy sources.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1996 Dec; 36(5):1239-50. PubMed ID: 8985050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monte Carlo and analytic calculation of absorbed dose near 137Cs intracavitary sources.
    Williamson JF
    Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):227-37. PubMed ID: 3391820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGSnrc-based Monte Carlo dosimetry of CSA1 and CSA2 137Cs brachytherapy source models.
    Selvam TP; Sahoo S; Vishwakarma RS
    Med Phys; 2009 Sep; 36(9):3870-9. PubMed ID: 19810459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A monte carlo study of dose rate distribution around the specially asymmetric CSM3-a 137Cs source.
    Pérez-Calatayud J; Lliso F; Balleste F; Serrano MA; Lluch JL; Limami Y; Puchades V; Casal E
    Phys Med Biol; 2001 Jul; 46(7):N169-174. PubMed ID: 11474943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Monte Carlo investigation of the dosimetric characteristics of the CSM11 137Cs source from CIS.
    Ballester F; Lluch JL; Limami Y; Serrano MA; Casal E; Pérez-Calatayud J; Lliso F
    Med Phys; 2000 Sep; 27(9):2182-9. PubMed ID: 11011749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monte Carlo calculation of dose rate distributions around the Walstam CDC.K-type 137Cs sources.
    Pérez-Calatayud J; Ballester F; Lluch JL; Serrano-Andrés MA; Casa E; Puchades V; Limami Y
    Phys Med Biol; 2001 Jul; 46(7):2029-40. PubMed ID: 11474942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric characteristics of the CDC-type miniature cylindrical 137Cs brachytherapy sources.
    Pérez-Calatayud J; Ballester F; Serrano-Andrés MA; Lluch JL; Puchades V; Limami Y; Casal E
    Med Phys; 2002 Apr; 29(4):538-43. PubMed ID: 11991125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of air kerma reference standard for low dose rate Cs-137 brachytherapy sources.
    Sharma SD; Kumar S; Srinivasan P; Chourasiya G
    J Appl Clin Med Phys; 2011 Nov; 12(4):3553. PubMed ID: 22089009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dose distribution surrounding 192Ir and 137Cs seed sources.
    Thomason C; Mackie TR; Lindstrom MJ; Higgins PD
    Phys Med Biol; 1991 Apr; 36(4):475-93. PubMed ID: 2047397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AAPM TG-43 formalism for brachytherapy dose calculation of a 137Cs tube source.
    Zhang P; Beddar AS; Sibata CH
    Med Phys; 2004 Apr; 31(4):755-9. PubMed ID: 15124992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of 137Cs dosimetry parameters according to the AAPM TG-43 formalism.
    Liu L; Prasad SC; Bassano DA
    Med Phys; 2004 Mar; 31(3):477-83. PubMed ID: 15070243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Room scatter studies in the air kerma strength standardization of the Amersham CDCS-J-type 137Cs source: a Monte Carlo study.
    Selvam TP; Rajan KN; Nagarajan PS; Bhatt BC; Sethulakshmi P
    Phys Med Biol; 2002 May; 47(9):N113-9. PubMed ID: 12043824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose rate calculations around 192Ir brachytherapy sources using a Sievert integration model.
    Karaiskos P; Angelopoulos A; Baras P; Rozaki-Mavrouli H; Sandilos P; Vlachos L; Sakelliou L
    Phys Med Biol; 2000 Feb; 45(2):383-98. PubMed ID: 10701510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of calculated and measured heterogeneity correction factors for 125I, 137Cs, and 192Ir brachytherapy sources near localized heterogeneities.
    Williamson JF; Perera H; Li Z; Lutz WR
    Med Phys; 1993; 20(1):209-22. PubMed ID: 8455503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric characteristics, air-kerma strength calibration and verification of Monte Carlo simulation for a new Ytterbium-169 brachytherapy source.
    Perera H; Williamson JF; Li Z; Mishra V; Meigooni AS
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):953-70. PubMed ID: 8138449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
    Ho Than MT; Munro Iii JJ; Medich DC
    J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo evaluation of the Sievert integral for brachytherapy dosimetry.
    Williamson JF; Morin RL; Khan FM
    Phys Med Biol; 1983 Sep; 28(9):1021-32. PubMed ID: 6634938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Source configuration and dose rates for the Selectron afterloading equipment for gynecologic applicators.
    Grigsby PW; Williamson JF; Perez CA
    Int J Radiat Oncol Biol Phys; 1992; 24(2):321-7. PubMed ID: 1526871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.